Kanghua Bio: Wu Wennian has accumulated about 17,500 shares in the company_Oriental Fortune Net Post date May 16, 2022 — 21:19 Post Lock Read More Kanghua Biotech (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian Post date May 16, 2022 — 21:16 Post Lock Read More Kanghua Biotechnology (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian Post date May 16, 2022 — 21:16 Post Lock Read More The biological vaccine sector moved up Post date May 12, 2022 — 13:04 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com Post date May 11, 2022 — 08:30 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotech (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian Post date May 16, 2022 — 21:16 Post Lock Read More Kanghua Biotechnology (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian Post date May 16, 2022 — 21:16 Post Lock Read More The biological vaccine sector moved up Post date May 12, 2022 — 13:04 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com Post date May 11, 2022 — 08:30 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotechnology (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian Post date May 16, 2022 — 21:16 Post Lock Read More The biological vaccine sector moved up Post date May 12, 2022 — 13:04 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com Post date May 11, 2022 — 08:30 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The biological vaccine sector moved up Post date May 12, 2022 — 13:04 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com Post date May 11, 2022 — 08:30 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com Post date May 11, 2022 — 08:30 Post Lock Read More At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings. Post date May 11, 2022 — 05:55 Post Lock Read More Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown Post date May 10, 2022 — 19:30 Post Lock Read More Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online Post date May 8, 2022 — 22:17 Post Lock Read More Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network Post date May 8, 2022 — 18:46 Post Lock Read More Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves Post date May 6, 2022 — 20:36 Post Lock Read More Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021" Post date May 6, 2022 — 11:46 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics Post date May 5, 2022 — 06:19 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm Post date May 4, 2022 — 02:56 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times. Post date May 3, 2022 — 20:41 Post Lock Read More The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, and over 70% of the results are good news – yqqlm Post date May 3, 2022 — 19:46 Post Lock Read More The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The first quarterly reports of these three companies reflect the trend of the whole year Post date May 1, 2022 — 12:51 Post Lock Read More Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Bosera Growth Enterprise Market ETF Link A Net Worth Up 3.79% Bosera Finance Post date April 30, 2022 — 09:38 Post Lock Read More
Caishen.CoCaishen.Co